Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet
Diabetes, Obesity and Metabolism, 08/28/09
Raskin P et al. – The repaglinide/metformin FDC BID regimen showed efficacy that was non–inferior to that of the rosiglitazone/metformin FDC BID regimen currently in clinical use and a more rapid reduction of HbA1c values. Thus, repaglinide/metformin FDC BID is a clinically feasible alternative to rosiglitazone/metformin FDC BID.
Related Articles
Therapeutic Drug Monitoring of Lopinavir in Human Immunodeficiency Virus-Infected Children Receiving Adult Tablets: Therapeutic Drug Monitoring of Lopinavir Tablets Given To Children
The Pediatric Infectious Disease Journal, 10/29/09
Relevance Score: 45%
Preparation of medicinal carbon tablets by modified wet compression method
Drug Development and Industrial Pharmacy, 10/29/09
Relevance Score: 42%
Cephalon Notified of Generic Filing for Armodafinil Tablets
Cephalon, 10/22/09
Relevance Score: 42%
Boehringer Ingelheim receives approval from the European Commission for Mirapexin/Sifrol prolonged-release, once daily tablet for the treatment of Parkinson`s disease
Boehringer Ingelheim, 10/15/09
Relevance Score: 42%
Mylan Announces Settlement Agreement Related to Vfend First-to-File Opportunity
Mylan, 10/15/09
Relevance Score: 42%
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs
Current Opinion in Lipidology, 12/15/09
Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/15/09
Effect of Obesity on Platelet Reactivity and Response to Low-Dose Aspirin
Preventive Cardiology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


